ZCA
TMO icon

Zeke Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Zeke Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.66M Buy
3,016
+988
+49% +$524K 0.11% 91
2022
Q3 		$1.03M Sell
2,028
-29
-1% -$16.2K 0.07% 117
2022
Q2 		$1.12M Buy
2,057
+40
+2% +$22K 0.07% 119
2022
Q1 		$1.19M Buy
+2,017
New +$1.16M 0.06% 126
2020
Q1 		– Sell
-4,986
Closed -$1.62M – 482
2019
Q4 		$1.62M Hold
4,986
– – 0.13% 129
2019
Q3 		$1.45M Sell
4,986
-21
-0.4% -$6.01K 0.13% 135
2019
Q2 		$1.47M Sell
5,007
-307
-6% -$84.6K 0.14% 133
2019
Q1 		$1.46M Sell
5,314
-1,788
-25% -$445K 0.14% 133
2018
Q4 		$1.59M Sell
7,102
-2,895
-29% -$679K 0.15% 114
2018
Q3 		$2.44M Buy
9,997
+33
+0.3% +$7.59K 0.2% 82
2018
Q2 		$2.06M Hold
9,964
– – 0.19% 88
2018
Q1 		$2.06M Buy
9,964
+19
+0.2% +$3.99K 0.19% 96
2017
Q4 		$1.89M Buy
9,945
+3,133
+46% +$600K 0.2% 83
2017
Q3 		$1.29M Buy
6,812
+3,324
+95% +$602K 0.18% 98
2017
Q2 		$609K Buy
3,488
+942
+37% +$158K 0.12% 113
2017
Q1 		$391K Buy
2,546
+545
+27% +$83.3K 0.08% 155
2016
Q4 		$282K Buy
+2,001
New +$295K 0.08% 144

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zeke Capital Advisors's TMO Position: Q4 2022 in Review

Zeke Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 49% in Q4 2022, buying an estimated $524K and bringing the position to 3,016 shares worth $1.66M. The position accounts for 0.11% of the portfolio, ranked #91.

Zeke Capital Advisors first reported a position in TMO in Q4 2016 and has held it in 17 quarters since. The position peaked at $2.44M in Q3 2018. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Zeke Capital Advisors held 3,016 shares of Thermo Fisher Scientific worth $1.66M as of Q4 2022.
  • Zeke Capital Advisors bought 988 Thermo Fisher Scientific shares in Q4 2022, an estimated $524K.
  • Thermo Fisher Scientific made up 0.11% of Zeke Capital Advisors's portfolio in Q4 2022, its #91 holding.
  • Zeke Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 17 quarters since.
  • Zeke Capital Advisors's Thermo Fisher Scientific position peaked at $2.44M in Q3 2018.
  • 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.